Emulate Inc. closes $82M Series E to fund expansion of ‘organ-on-a-chip’ products
TechCrunch
SEPTEMBER 7, 2021
The NIH has launched them into spac e to study the effects of spaceflight, and has been developing tissue chip testing and validation programs since 2010. A lot of that growth will depend on the potential for an organ-on-a-chip to disrupt the preclinical side of the drug testing process.
Let's personalize your content